Diego Medina-Valencia1, Alejandro Castillo-Martínez2, Estefanía Beltrán3, Eliana Manzi4, Amparo Chantre-Mostacilla5, Gloria Piedad Guerrero-Fajardo5, Mayra Estacio4, Alexis A Franco6. 1. Departamento Materno-infantil, Unidad de Trasplante de Médula Ósea, Fundación Valle del Lili, Cali, Colombia; Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia. trasplantemedulaoseapediatrico@fvl.org.co. 2. Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia; Departamento de Psiquiatría, Fundación Valle del Lili, Cali, Colombia. biomedica@ins.gov.co. 3. Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia. biomedica@ins.gov.co. 4. Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia; Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia. biomedica@ins.gov.co. 5. Departamento Materno-infantil, Unidad de Trasplante de Médula Ósea, Fundación Valle del Lili, Cali, Colombia. biomedica@ins.gov.co. 6. Departamento Materno-infantil, Unidad de Trasplante de Médula Ósea, Fundación Valle del Lili, Cali, Colombia; Facultad de Ciencias de la Salud, Universidad Icesi, Cali, Colombia. biomedica@ins.gov.co.
Abstract
Introduction: Hematopoietic stem cell transplantation is the curative option for some diseases and is increasing patient survival. The health-related quality of life in these patients is not systematically evaluated. Objectives: The present study sought to describe the health-related quality of life and complications in children who underwent hematopoietic stem cell transplantation. Materials and methods: A cross-sectional study was conducted on pediatric transplanted survivors. Health-related quality of life was measured using the KIDSCREEN-27 scale and Short Form-12 (SF-12) in patients between 8 and 14 years of age and those over 14 years, respectively. Statistical analysis was performed using STATA 12 software. We used the Rasch model person parameter estimates translated into T-values to score the questionnaire. Results: A total of 42 children answered the questionnaires. The most frequent adverse events were chronic graft Vs. host disease and endocrine complications. According to European norm data in the KIDSCREEN-12 scale, scores for the school dimension and social and peer support were below the 50th. percentile. The group administered immunosuppressants had lower scores on the physical component of the SF-12™ scale. Conclusions: In general, the KIDSCREEN-27 does appear to suggest some quality-of-life deficit in younger children. The scales showed reliability in this population.
Introduction: Hematopoietic stem cell transplantation is the curative option for some diseases and is increasing patient survival. The health-related quality of life in these patients is not systematically evaluated. Objectives: The present study sought to describe the health-related quality of life and complications in children who underwent hematopoietic stem cell transplantation. Materials and methods: A cross-sectional study was conducted on pediatric transplanted survivors. Health-related quality of life was measured using the KIDSCREEN-27 scale and Short Form-12 (SF-12) in patients between 8 and 14 years of age and those over 14 years, respectively. Statistical analysis was performed using STATA 12 software. We used the Rasch model person parameter estimates translated into T-values to score the questionnaire. Results: A total of 42 children answered the questionnaires. The most frequent adverse events were chronic graft Vs. host disease and endocrine complications. According to European norm data in the KIDSCREEN-12 scale, scores for the school dimension and social and peer support were below the 50th. percentile. The group administered immunosuppressants had lower scores on the physical component of the SF-12™ scale. Conclusions: In general, the KIDSCREEN-27 does appear to suggest some quality-of-life deficit in younger children. The scales showed reliability in this population.
Entities:
Keywords:
Bone marrow transplantation; quality of life; child; mental health
Authors: L Wengenroth; M E Gianinazzi; C S Rueegg; S Lüer; E Bergstraesser; C E Kuehni; G Michel Journal: Qual Life Res Date: 2015-03-18 Impact factor: 4.147
Authors: J A Oberg; J G Bender; E Morris; L Harrison; C E Basch; J H Garvin; S A Sands; M S Cairo Journal: Bone Marrow Transplant Date: 2012-11-19 Impact factor: 5.483
Authors: Josef Nathan Jensen; Frederik Gøtzsche; Carsten Heilmann; Henrik Sengeløv; Lis Adamsen; Karl Bang Christensen; Hanne Baekgaard Larsen Journal: Pediatr Transplant Date: 2016-05-27
Authors: Kris Ann P Schultz; Lu Chen; Zhengjia Chen; Toana Kawashima; Kevin C Oeffinger; William G Woods; H Stacy Nicholson; Joseph P Neglia Journal: Pediatr Blood Cancer Date: 2013-11-27 Impact factor: 3.167